Answer & Explanation:A company uses patient DNA for research without the patient’s knowledge or informed consentDiscuss the scenario as a team and identify similar and opposing ethical opinions.Prepare a 12- to 15- slide Microsoft® PowerPoint® presentation with detailed speaker notes that addresses the ethical implications of the chosen scenario.Include the following in your presentation:Explain the ethical implications of health care researchSummarize how ethics can lead to bias that influence health care researchSummarize prior research findings related to the ethical issueLike I said I need just an introduction and conclusion on this. I will attach what I have so far for you. please try to get back in 8 hrs. I am still missing 3 slides from the question on 2nd bullet point.
ppt_team_a_wk_5.pptx
Unformatted Attachment Preview
Ethical Scenario
YESICA TATE, ALAN SAMPSON,
KIA HENDERSON-MARSHALL, OBINNA, NGOBIL
TEAM A
SEPTEMBER 14, 2016
STEPHANIE HOLDEN
Introduction – Obi
Ethical implications of health care research
– Yesica
Treatment denial
Racial
discriminations
Education level
Ethical implications of health care
research
Social
media
Malpractice
Confidentiality
Henrietta Lacks
Summary:
A story of a family trying to make peace when discovering
that “Henrietta Lacks” who perished to cervical cancer in
1951 while receiving treatment at John Hopkins Hospital. A
scientist by the name of “George Gey” used her cells for
further research without consent and then discovers that her
cells continue to reproduce.
(Le Roux, 2011)
Elixir Sulfanilamide
Summary:
Another story that took a ethical decision to use “Elixir
Sulfanilamide” in antibiotics in 1937. The drug caused over
100 deaths in 15 states, many of the deaths were children.
In response to a public outcry congress passed the 1938
Food, Drug, and Cosmetic Act, which significantly
changed drug regulation in the United States. The law
enabled the US Food and Drug Administration more
enforcement over drug products and revamped the
current drug approval process.
(Jarrell, (2012)
Ethical Challenges Within Veterans
Administration
Summary:
A qualitative/content analysis study conducted on Ethical
Challenges Within Veterans Administration Healthcare
Facilities. This analysis was part of a larger effort to develop
and validate the content of the Integrated Ethics Staff Survey
(IESS). The survey is an a national educational and
organizational change created by the VHA administration in
Washington, DC and a initiative to establish a standardized,
comprehensive, systems-focused model for improving ethics
quality in healthcare.
(Foglia, Pearlman, Bottrell, Altemose, & Fox, 2009)
Summary of Data Collection
(Foglia, Pearlman, Bottrell, Altemose, & Fox, 2009)
Summary of Data Collection
(Foglia, Pearlman, Bottrell, Altemose, & Fox, 2009)
Conclusion – Obi
References
Foglia, M. B., Pearlman, R. A., Bottrell, M., Altemose, J. K., & Fox, E. (2009). Ethical challenges within
veterans administration healthcare facilities: Perspectives of managers, Clinicians, patients, and ethics
committee Chairpersons. The American Journal of Bioethics, 9(4), 28–36.
Holm, S. (2003). The ethical case against stem cell research. Cambridge Quarterly of Healthcare Ethics,
12(04).
Jarrell, K. (2012). Regulatory history: Elixir sulfanilamide. Journal of GXP Compliance, 16(3), 12-14.
Le Roux, T. (2011). Review essay: The immortal life of Henrietta lacks. Journal of Family Theory &
Review, 3(1), 54–57.
…
Purchase answer to see full
attachment
